The Uromigos

The Uromigos

THE UROMIGOSTHE UROMIGOS
Release Date

All Episodes

Episode 517: Casdatifan Clinical Data in RCC and Translational Correlates

Toni Choueiri joins Brian and Tom to discuss a recent Nature paper regarding the novel HIF inhibitor, casdatifan, and biomarkers of response. 

 . 40min 53sec
Episode 516: The Influence of Hypoxia on Response and Resistance in RCC

Ari Hakimi and Lyn Voung from MSKCC join Brian and Tom to discuss their recent Cancer Cell paper exploring the mechanistic impact of TKI-induced hypoxia on immune response in RCC. 

 . 47min 50sec
Episode 515: PROTEUS - A Reflection on the Data and Controversies with Neha Vapiwala

Brian and Tom invite Neha Vapiwala, a Radiation Oncologist, to discuss areas of consensus and controversy from the PROTEUS trial of ADT +/- apalutamide in high-risk localized prostate cancer. 

 . 43min 6sec
Episode 514: Artificial Intelligence in Cancer Drug Development

Travis Zack, CMO of Open Evidence, joins Brian and Tom to discuss the emergence of AI across the spectrum on cancer, drug development and application of data. 

 . 40min 24sec
Episode 513: Trials and Tribulations of Investigator-initiated Research

Bishoy Faltas joins Brian and Tom to discuss his IIT in bladder cancer. The intended discussion of the trials turned into an insightful discussion on the challenges and learning opportunities of IITs. 

 . 25min 34sec